Document Detail


Protecting the people?: risk communication and the chequered history and performance of bureaucracy.
MedLine Citation:
PMID:  23061778     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The history and characteristics of bureaucracy1 are examined with a view to understanding the impact of the bureaucratic mindset on medicines' regulation, the pharmaceutical industry and healthcare delivery with a focus on risk communication, pharmacovigilance and patient safety. Controversies and allegations relating to common, negative effects of bureaucratic regulatory and management systems are reviewed and examples of creative and effective practice provided. Strategic directions and specific actions for reform are proposed.2.
Authors:
Bruce Hugman
Related Documents :
11057728 - Monitoring insect pests in retail stores by trapping and spatial analysis.
23199178 - Regional health systems and non-conventional medicine: the situation in italy.
23642958 - Systems biology approach opens door to essence of acupuncture.
19492888 - Document control practices in 120 clinical laboratories.
1125658 - The trainee year--a critical appraisal.
21530028 - Traumatic brain injury: review of current management strategies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug safety : an international journal of medical toxicology and drug experience     Volume:  35     ISSN:  0114-5916     ISO Abbreviation:  Drug Saf     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002928     Medline TA:  Drug Saf     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  1005-25     Citation Subset:  IM    
Affiliation:
Uppsala Monitoring Centre, Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Challenges of drug risk communications in the Philippines.
Next Document:  Risk Communication and the Pharmaceutical Industry: What is the Reality?